References
- 1. Maricevich MA, Adair MJ, Maricevich RL, Kashyap R, Jacobson SR. Facelift complications related to median and peak blood pressure evaluation. Aesthetic Plast Surg. 2014;38(4):641-7.10.1007/s00266-014-0353-z24912427
- 2. Park DM. Total facelift: Forehead lift, midface lift, and neck lift. Arch Plast Surg. 2015;42(2):111-25.10.5999/aps.2015.42.2.111436669125798381
- 3. Cason RW, Avashia YJ, Shammas RL, Savetsky IL, Rohrich RJ. Perioperative approach to reducing hematoma during rhytidectomy: What does the evidence show? Plast Reconstr Surg. 2021;147(6):1297-309.10.1097/PRS.000000000000794333974595
- 4. Swanson E. Evaluation of face lift skin perfusion and epinephtine effect using laser fluorescence imaging. Plast Reconstr Surg Glob Open. 2015;3(8):e484.10.1097/GOX.0000000000000469456021726495197
- 5. Baker DC, Stefani WA, Chiu ES. Reducing the incidence of hematoma requiring surgical evacuation following male rhytidectomy: A 30-year review of 985 cases. Plast Reconstr Surg. 2005;116(7):1973-85.10.1097/01.prs.0000191182.70617.e916327611
- 6. Swanson E. Prospective study of Doppler ultrasound surveillance for deep venous thromboses in 1000 plastic surgery outpatients. Plast Reconstr Surg. 2020;145:85-96.10.1097/PRS.000000000000634331881608
- 7. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615-27.10.2147/VHRM.S2471
- 8. Chung KH, Cho MS, Jin H. Perioperative hypertension management during facelift under local anesthesia with intravenous hypnotics. Arch Plast Surg. 2017;44(4):276-82.10.5999/aps.2017.44.4.276553306628728322
- 9. Trussler AP, Hatef DA, Rohrich RJ. Management of hypertension in the facelift patient: results of a national consensus survey. Aesthet Surg J. 2011;31:493-500.10.1177/1090820X1141129221719861
- 10. Conn HO. Portal hypertension, varices and transjugular intrahepatic portosystemic shunts. Clin Liver Dis. 2000;4(1):133-50.10.1016/S1089-3261(05)70100-811232181
- 11. Gunarathne LS, Rajapaksha H., Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: from pathophysiology to novel therapeutics. World J Gastroenterol. 2020;26(40):6111-40.10.3748/wjg.v26.i40.6111759664233177789
- 12. Königshofer P, Brusilovskaya K, Schwabl P, Reiberger T. Animal models of portal hypertension. Biochim Biophys Acta Mol Basis Dis. 2019;1865(5):1019-30.10.1016/j.bbadis.2018.07.01830055295
- 13. Abraldes JG, Pasarin M, Garcia-Pagan JC. Animal model of portal hypertension. World J Gastroenterol. 2006;12(41):6577-84.10.3748/wjg.v12.i41.6577412566017075968
- 14. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618-G25.10.1152/ajpgi.1985.248.6.G6184003545
- 15. Zhu W, Song H. A rare case of recurrent lower extremity ulcer. Int J Low Extrem Wounds. 2019;18(4):389-92.10.1177/153473461987009831464167
- 16. Van Buuren HR, Fick TE, Schalm SW. Recurrent bleeding from cutaneous venous collaterals in portal hypertension. Gut. 1988;29(9):1279-81.10.1136/gut.29.9.127914343633198005
- 17. Godara SK, Thappa DM, Pottakkatt B, Hamide A, Barath J, Munisamy M, et al. Cutaneous manifestations in disorders of hepatobiliary system. Indian Dermatol J Online. 2017;8(1):9-15.10.4103/2229-5178.198760529728728217465
- 18. Sato I. Cutaneous manifestations of liver cirrhosis. Nihon Rinsho. 1994;52(1):170-3.
- 19. Hrytsevych NR, Vereschaka VV. Features of the ultrastructure of the skin of white rats 60 and 90 days after modeling of portal hypertension. Wiad Lek. 2021;74(9 part 1):2197-201.10.36740/WLek202109130